Table 3:

Characteristics of left ventricular ejection fraction and clinical outcomes

Variable or outcomeGroup; mean (95% CI) or no. (%) of patients
Placebo
n = 42
G-CSF
n = 42
p value
Left ventricular ejection fraction, %
Baseline36.4 (33.5–39.2)34.8 (32.6–37.0)0.4
6 wk43.1 (39.2–47.0)39.8 (36.2–43.4)0.2
26 wk46.0 (42.7–44.3)40.8 (37.4–44.2)0.04
Change, baseline to 26 wk, percentage points9.2 (6.3–12.1)5.7 (3.4–8.1)0.07
Outcome
Major adverse cardiac event8 (19)8 (19)> 0.9
Death1 (2)1 (2)> 0.9
Coronary artery bypass graft1 (2)1 (2)> 0.9
Cardiac transplant0 (0)1 (2)> 0.9
Cerebrovascular accident0 (0)1 (2)> 0.9
Target-vessel revascularization6 (14)5 (12)> 0.9
Heart failure requiring admission3 (7)1 (2)> 0.9
  • Note: CI = confidence interval, G-CSF = granulocyte colony-stimulating factor.